LisaChirchMD

PubMed

• High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training Programs.
  Luther, V., Shnekendorf, R., , Paras, M., Schultz, S., Aziz, M., Balba, G., McCarty, T., Razonable, R., Reece, R., Sundareshan, V., Chirch, L.> ;Open Forum Infectious Diseases. 2024 Mar 1
• Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program Directors.
  Vera P Luther, Alice E Barsoumian, Victoria J L Konold, Tara Vijayan, Gayle Balba, Constance Benson, Brian Blackburn, Paloma Cariello, Sarah Perloff, Raymund Razonable...> ;Open Forum Infectious Diseases. 2023 Jun 1
• 15 citations
  Virtual Recruitment Is Here to Stay: A Survey of ID Fellowship Program Directors and Matched Applicants Regarding Their 2020 Virtual Recruitment Experiences.
  Danica Rockney, Constance A. Benson, Brian G. Blackburn, Lisa M. Chirch, Victoria J L Konold, Vera P. Luther, Raymund R. Razonable, Sean Tackett, Michael T. Melia> ;Open Forum Infectious Diseases. 2021 Aug 1
• Evaluation of Provider Screening Practices for Fracture Risk Assessment among Patients with HIV Disease.
  Faryal S. Mirza, Sabina Zawadzka, Anne Abbate, Michael Christopher. Thompson, Dorothy Wakefield, Lisa M. Chirch> ;AIDS Research and Treatment. 2021 Jan 1
• 4 citations
  Education of Infectious Diseases Fellows During the COVID-19 Pandemic Crisis: Challenges and Opportunities
  Lisa M. Chirch, Wendy S. Armstrong, Gayle P. Balba, Prathit A. Kulkarni, Constance A. Benson, Victoria J L Konold, Vera P. Luther, Obinna N. Nnedu, Sarah Perloff, Raym...> ;Open Forum Infectious Diseases. 2021 Feb 1
• 2 citations
  Isoniazid-Resistant Tuberculosis of the Parotid Gland Masquerading as a Benign Neoplasm.
  Subin Lee, Lisa M. Chirch, Lynn Sosa, Qian Wu, Todd E. Falcone> ;Ear, Nose, & Throat Journal. 2020 Jun 30
• 4 citations
  The struggling infectious diseases fellow: Remediation challenges and opportunities
  Michael T. Melia, Armando Paez, Gail E. Reid, Lisa M. Chirch, Vera P. Luther, Brian G. Blackburn, Federico Perez, Emily Abdoler, Daniel R. Kaul, Susan J. Rehm, Nada Ha...> ;Open Forum Infectious Diseases. 2020 Mar 1
• 6 citations
  Thyroid Eye Disease due to Immune Reconstitution Inflammatory Syndrome as a Consequence of Antiretroviral Therapy in the Setting of AIDS.
  Ravali Nallu, Parvathy Madhavan, Lisa M. Chirch, Pooja Luthra> ;Case Reports in Endocrinology. 2020 Feb 12
• 6 citations
  Tuberculosis and interleukin blocking monoclonal antibodies: Is there risk?
  Andrew Kelsey, Lisa M. Chirch, Michael J. Payette> ;Dermatology Online Journal. 2018 Sep 15
• 8 citations
  Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patients.
  Donald P. Rice, Michelle A. Ordoveza, Ann Palmer, George Y. Wu, Lisa M. Chirch> ;AIDS Care. 2018 Jul 18
• 4 citations
  Drug-Induced Sweet Syndrome in a Man With Sarcoidosis: Are There Any Common Mechanisms of Pathogenesis?
  Elena Gkrouzman, Lisa M. Chirch, Santhanam Lakshminarayanan> ;Journal of Clinical Rheumatology. 2018 Mar 1
• 24 citations
  Endocrinological aspects of HIV infection.
  Faryal S. Mirza, Pooja Luthra, Lisa M. Chirch> ;Journal of Endocrinological Investigation. 2018 Jan 8
• Pulmonary artery intravascular abscess: A rare complication of incomplete infective endocarditis treatment in the setting of injection drug use.
  Simran Gupta, David B. Banach, Lisa M. Chirch> ;Idcases. 2018 Jan 1
• 9 citations
  HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals.
  Donald P. Rice, John J. Faragon, Sarah J. Banks, Lisa M. Chirch> ;Journal of Clinical and Translational Hepatology. 2016 Sep 25
• 5 citations
  Ecthyma gangrenosum secondary to methicillin-sensitive Staphylococcus aureus
  Jurate Ivanaviciene, Lisa M. Chirch, Jane M. Grant-Kels, Philip Kerr, Justin Finch> ;International Journal of Women's Dermatology. 2016 Sep 1
• 2 citations
  The Addition of High-Risk HPV Testing to Anal Cytology Increases the Identification of Anal Dysplasia in HIV-Infected Patients.
  Paul Anthony, Richard Feinn, Bruce Brenner, Kevin D. Dieckhaus, Lisa M. Chirch> ;Connecticut Medicine. 2015 Aug 1
• Reply to: "Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors".
  Lisa M. Chirch, Kevin D. Dieckhaus, Jane M. Grant-Kels> ;Journal of the American Academy of Dermatology. 2015 Apr 1
• 14 citations
  Nontuberculous mycobacterial infections: a potential complication of cosmetic procedures
  Tiara T. Hypolite, Jane M. Grant-Kels, Lisa M. Chirch> ;International Journal of Women's Dermatology. 2015 Feb 1
• 5 citations
  Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes.
  Gavin Cloherty, Priscilla Swanson, Danijela Lucic, Kevin D. Dieckhaus, Paul Anthony, Philip R. Cataline, Christine Herman, John Hackett, Paul R. Skolnik, Lisa M. Chirch> ;Journal of Virological Methods. 2014 Aug 1
• 10 citations
  Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part I. Risks associated with tumor necrosis fact...
  Lisa M. Chirch, Philip R. Cataline, Kevin D. Dieckhaus, Jane M. Grant-Kels> ;Journal of the American Academy of Dermatology. 2014 Jul 1
• 5 citations
  Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis...
  Lisa M. Chirch, Philip R. Cataline, Kevin D. Dieckhaus, Jane M. Grant-Kels> ;Journal of the American Academy of Dermatology. 2014 Jul 1
• 9 citations
  HIV and aging: a clinical journey from Koch's postulate to the chronic disease model and the contribution of geriatric syndromes.
  Lisa M. Chirch, Mohamed Hasham, George A. Kuchel> ;Current Opinion in HIV and AIDS. 2014 Jul 1
• 1 citations
  Update on Hepatitis C Virus and HIV Coinfection
  Tilahun Amdissa Gemtessa, Lisa M. Chirch> ;Journal of Clinical and Translational Hepatology. 2013 Dec 28
• 902 citations
  The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
  Yang, O. O., Florencia Pereyra, Xiaoming Jia, Paul J. McLaren, Amalio Telenti, de Bakker Pi, Bruce D. Walker, Stephan Ripke, Chanson J. Brumme, Sara L. Pulit, Mary Car...> ;Science. 2010 Dec 10
• 1 citations
  Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection
  Lisa M. Chirch, Roy T. Steigbigel> ;Infection and Drug Resistance. 2010 Apr 26
• Join now to see all